Clinical Compass™
From Guidelines to Documentation Support — Bridging Bedside Decisions to Treatment Plan Execution
A unified platform of evidence-based clinical decision support tools that translates complex subspecialty guidelines into intuitive, patient-specific pathways — bridging the gap between clinical decision-making and the documentation needed to support every step of the patient treatment plan.
How It Works
From the first patient encounter to a successfully approved procedure — three steps, fully evidence-based.
Enter Patient Data
Input clinical findings, lab values, imaging results, and relevant history into the module's guided wizard. No free-text — structured inputs ensure nothing is missed.
Get a Guideline-Based Recommendation
The module applies the latest society guidelines (ACC/AHA, AUA, ASRM, WPATH, SIR, NCCN) to generate a patient-specific recommendation with cited evidence and risk stratification.
Generate Auth & Appeal Documentation
Export a ready-to-submit prior authorization guide with payer-specific criteria, or generate a fully drafted, evidence-based appeal letter citing society guidelines — built to overturn denials.
Clinical Decision Modules
Each module translates specialty-specific guidelines into structured, patient-specific decision pathways that clinicians can use at the point of care.
Surgery & Surgical Oncology
Colorectal, hepatobiliary, bariatric, and spine surgery decision support
Rectal Cancer Clinical Compass
Rectal Cancer: TNT vs Surgery vs Watch-and-Wait Decision Support
A clinical decision support tool for rectal cancer management based on NCCN Rectal Cancer v2.2025, ESMO 2024 Rectal Cancer Guidelines, and landmark trials (RAPIDO, PRODIGE 23, OPRA, FOWARC). Guides clinicians through staging, total neoadjuvant therapy (TNT) vs standard chemoradiation, watch-and-wait eligibility (cCR assessment), and surgical extent (TME, TEM, APR). Incorporates MSI/MMR status, EMVI, and MRF involvement.
Liver Tumor Clinical Compass
Liver Tumor: Resection vs Ablation vs Embolization Decision Support
A clinical decision support tool for liver tumor management based on EASL 2024 HCC Clinical Practice Guidelines, AASLD 2023 HCC Guidance, NCCN Hepatobiliary v2.2025, and SIR 2024 Ablation Guidelines. Guides clinicians through BCLC staging, resection candidacy (FLR assessment, portal vein embolization), ablation selection (RFA, MWA, cryoablation), and embolization strategies (TACE, TARE/Y-90, TAE) for HCC, colorectal liver metastases, and intrahepatic cholangiocarcinoma.
Obesity Treatment Clinical Compass
Obesity: ESG vs GLP-1 vs Bariatric Surgery Decision Support
A clinical decision support tool for obesity treatment selection based on ASMBS/IFSO 2022 Indications for Metabolic and Bariatric Surgery, AHA/ACC 2023 Obesity and CVD Guidelines, and SURMOUNT-1/SELECT/STEP trials. Guides clinicians through BMI-based eligibility, comorbidity weighting, GLP-1 agonist selection (semaglutide, tirzepatide), endoscopic sleeve gastroplasty (ESG) candidacy, and bariatric surgery selection (RYGB, sleeve gastrectomy, OAGB).
Spine Surgery Clinical Compass
Spine: When NOT to Operate — Conservative vs Surgical Decision Support
A clinical decision support tool for spine surgery decision-making based on NASS Evidence-Based Clinical Guidelines 2024, ACS Choosing Wisely 2023, and landmark RCTs (SPORT, STIR, ACDF vs conservative). Identifies red flags (cauda equina, myelopathy, progressive neurologic deficit) requiring urgent surgery, and guides clinicians through evidence-based conservative management pathways for lumbar disc herniation, lumbar stenosis, cervical radiculopathy, and degenerative disc disease.
ENT, Endocrine & Sleep Medicine
Thyroid nodule evaluation, OSA management, and head & neck surgery
Thyroid Nodule Clinical Compass
Thyroid Nodule: Biopsy vs Observe vs Operate Decision Support
A clinical decision support tool for thyroid nodule evaluation based on ACR TI-RADS 2017, ATA Management Guidelines 2023 Update, and the Bethesda System for Reporting Thyroid Cytopathology 2023. Calculates TI-RADS score (TR1–TR5), determines FNA biopsy thresholds by size and risk category, interprets Bethesda categories I–VI, and integrates molecular testing (ThyroSeq v3, Afirma GSC) for indeterminate cytology to guide surgical decision-making.
OSA Clinical Compass
OSA: CPAP vs Surgery vs Device (Inspire HNS) Decision Support
A clinical decision support tool for obstructive sleep apnea (OSA) treatment selection based on AASM Clinical Practice Guideline 2024, AAO-HNS Adult Snoring Guideline 2019, and the STAR/EFFECT trials for hypoglossal nerve stimulation (Inspire). Guides clinicians through AHI-based severity classification, CPAP adherence assessment, HNS (Inspire) eligibility criteria, oral appliance suitability, and surgical options (UPPP, tonsillectomy, MMA, nasal surgery) with cardiovascular risk stratification.
Narcolepsy Clinical Compass
Narcolepsy: Diagnosis & Treatment Decision Support
A clinical decision support tool for narcolepsy (NT1 and NT2) based on AASM Clinical Practice Guideline for the Treatment of Central Disorders of Hypersomnolence (2021). Guides clinicians through ICSD-3 diagnostic criteria, MSLT/PSG interpretation, CSF hypocretin-1 testing, and pharmacotherapy selection including modafinil, pitolisant, sodium oxybate (Xyrem/Lumryz), and solriamfetol with payer authorization and appeal documentation support.
Chronic Insomnia Clinical Compass
Chronic Insomnia: CBT-I vs Pharmacotherapy Decision Support
A clinical decision support tool for chronic insomnia disorder in adults based on AASM Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia (2017) and the 2026 AASM Guideline on Combination CBT-I and Pharmacotherapy. Guides clinicians through CBT-I first-line therapy, stepped-care pharmacotherapy (doxepin, eszopiclone, zolpidem, lemborexant, suvorexant), comorbidity assessment, and prior authorization documentation for orexin receptor antagonists.
Central Sleep Apnea Clinical Compass
Central Sleep Apnea: ASV vs CPAP vs BPAP Decision Support
A clinical decision support tool for central sleep apnea (CSA) in adults based on AASM Clinical Practice Guideline for the Treatment of Central Sleep Apnea (2025). Guides clinicians through CSA etiology classification, ASV vs CPAP vs BPAP-ST selection, SERVE-HF contraindication screening (EF<45%), and tirzepatide (Zepbound) FDA-approved use for OSA with obesity (SURMOUNT-OSA: 50.7% AHI reduction). Includes prior authorization and appeal documentation.
RLS / PLMD Clinical Compass
Restless Legs Syndrome & PLMD: Iron vs Alpha-2-Delta vs Dopamine Decision Support
A clinical decision support tool for restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) based on AASM Clinical Practice Guideline (2024). Implements the IRLSSG diagnostic criteria, serum ferritin threshold (>75 mcg/L), and the updated 2024 recommendation against dopamine agonists (pramipexole, ropinirole) as first-line due to augmentation risk. Strongly recommends gabapentin enacarbil, pregabalin, and IV ferric carboxymaltose for iron-deficient patients. Includes GLP-1 agonist interaction notes and payer authorization support.
OSA + Obesity Clinical Compass
OSA + Obesity: Zepbound (Tirzepatide) & Semaglutide Adjunct Therapy Decision Support
A clinical decision support tool for obstructive sleep apnea (OSA) with obesity, focusing on tirzepatide (Zepbound) and semaglutide as adjunct pharmacologic therapies. Based on SURMOUNT-OSA Phase 3 trials (N Engl J Med 2024;391:1193-205) and FDA approval of Zepbound on December 20, 2024 as the first and only prescription medication for moderate-to-severe OSA in adults with obesity. Guides clinicians through OSA severity classification, obesity criteria, T2DM exclusion, PAP therapy status, contraindication screening, and prior authorization documentation for tirzepatide.
Interventional Radiology
Image-guided minimally invasive procedures and vascular interventions
Pulmonary Embolism Clinical Compass
Pulmonary Embolism Decision Support
A structured clinical decision support tool for pulmonary embolism management based on the 2026 AHA/ACC multi-society guideline (Circulation 2026;153:e977–e1051). Guides clinicians through PE Clinical Categories (A–E), PESI/sPESI scoring, hemodynamic assessment, and evidence-based treatment selection — from anticoagulation to catheter-directed therapy and ECMO candidacy.
Women's Health Clinical Compass
Women's Health Decision Support
A unified clinical decision support platform for women's health interventions. Includes Pelvic Venous Disorder (PeVD) assessment and Uterine Fibroid Embolization (UFE) candidacy evaluation based on ACOG 2024 and SIR guidelines.
Prostatic Artery Embolization Clinical Compass
Prostatic Artery Embolization Decision Support
A clinical decision support tool for prostatic artery embolization (PAE) patient selection, implementing evidence-based criteria for benign prostatic hyperplasia management. Guides interventional radiologists and urologists through patient candidacy assessment, symptom scoring, imaging requirements, and contraindication screening based on SIR and AUA guidelines.
Varicocele Embolization Clinical Compass
Varicocele Embolization Decision Support
A clinical decision support tool for varicocele management integrating AUA/ASRM 2022, EAU 2024, CIRSE 2023, and SIR guidelines. Guides clinicians through Dubin-Amelar grading, treatment indication assessment (infertility, pain, adolescent atrophy), and evidence-based selection between percutaneous embolization and microscopic varicocelectomy — including recurrent varicocele after prior surgery.
Portal Hypertension Clinical Compass
Portal Hypertension Decision Support
A comprehensive clinical decision support tool for portal hypertension and portal vein complications based on Baveno VII (2022/2024 update), AASLD 2024, EASL 2024, SIR 2024, and ACG 2022 guidelines. Guides clinicians through portal vein thrombosis (PVT) anticoagulation, variceal prophylaxis and acute bleed management, ascites/refractory ascites, SBP prophylaxis, hepatic encephalopathy, hepatorenal syndrome (HRS-AKI with terlipressin), and TIPS candidacy — with liver transplant integration throughout.
Geniculate Artery Embolization Clinical Compass
Geniculate Artery Embolization Decision Support
A decision support tool for genicular artery embolization (GAE) in the management of knee osteoarthritis. Assists interventional radiologists and referring physicians in patient selection, procedural planning, and outcomes stratification based on current SIR and peer-reviewed evidence.
Percutaneous AV Fistula Clinical Compass
Percutaneous AV Fistula Creation Decision Support
A clinical decision support tool for percutaneous arteriovenous fistula (pAVF) creation for dialysis access, implementing the 2025 SIR Practice Guidance Document (Dolmatch et al.). Guides clinicians through patient eligibility, vessel mapping criteria, device selection (WavelinQ vs Ellipsys), CPT coding, and post-procedure maturation surveillance.
Bone Cancer Interventional Oncology Clinical Compass
Bone Cancer Interventional Oncology Decision Support
A clinical decision support tool for bone cancer interventional oncology assessment based on NCCN 2026 Principles of Interventional Oncology (SIO) guidelines. Guides interventional radiologists through patient selection, tumor characterization, ablation modality selection (RFA, MWA, cryoablation), embolization strategies, and contraindication screening for osteosarcoma, chondrosarcoma, GCTB, ABC, bone metastases, and chordoma.
Y-90 Radioembolization Clinical Compass
Y-90 Radioembolization Decision Support
A clinical decision support tool for yttrium-90 radioembolization patient selection and candidacy assessment based on EASL 2024, AASLD 2023, and SIR Guidelines 2024. Guides interventional radiologists through HCC staging (BCLC), intrahepatic cholangiocarcinoma (iCCA) treatment lines, portal vein involvement assessment, dosimetry planning, and contraindication screening for optimal patient selection and procedural planning.
Endovenous Ablation Clinical Compass
Endovenous Laser & Radiofrequency Ablation Decision Support
A clinical decision support tool for endovenous ablation (EVLA/RFA) patient selection based on the 2022 SVS/AVF/AVLS Clinical Practice Guidelines. Guides clinicians through CEAP classification, duplex ultrasound criteria, VCSS scoring, compression therapy requirements, and contraindication screening for optimal patient selection for laser or radiofrequency ablation of incompetent truncal veins.
Sclerotherapy Clinical Compass
Foam & Liquid Sclerotherapy Decision Support
A clinical decision support tool for sclerotherapy patient selection based on the 2022 SVS/AVF/AVLS Guidelines and European Guidelines on Sclerotherapy. Guides clinicians through CEAP classification, vessel type assessment, foam vs. liquid selection, contraindication screening (including PFO and migraine with aura for foam), and insurance coverage criteria for telangiectasias, reticular veins, and varicose veins.
Vertebroplasty / Kyphoplasty Clinical Compass
Vertebral Augmentation Decision Support
A clinical decision support tool for vertebroplasty and kyphoplasty patient selection based on VERTOS II/IV trial data, ACR Appropriateness Criteria (2022), and CMS LCD L35050. Guides clinicians through fracture age, MRI bone marrow edema assessment, VAS/Oswestry scoring, posterior wall integrity, conservative therapy requirements, and procedure selection (vertebroplasty vs. kyphoplasty) for osteoporotic, traumatic, and pathologic vertebral compression fractures.
Sacroplasty Clinical Compass
Sacral Insufficiency Fracture Decision Support
A clinical decision support tool for percutaneous sacroplasty patient selection based on ACR Appropriateness Criteria (2022) and published prospective series (Frey et al., Spine 2017). Guides clinicians through Denis zone classification, MRI bone marrow edema assessment, VAS pain scoring, functional impairment evaluation, conservative therapy requirements, and contraindication screening for sacral insufficiency fractures from osteoporosis, malignancy, or radiation.
Peripheral Atherectomy Clinical Compass
Peripheral Atherectomy Patient Selection & Authorization
A clinical decision support tool for peripheral atherectomy patient selection based on the 2024 ACC/AHA PAD guideline (Gornik HL et al., Circulation 2024), SIR/OEIS/SCAI consensus, TASC II classification, and GLASS staging. Guides clinicians through Rutherford classification, lesion characterization (calcification, length, location), atherectomy modality selection (directional, orbital, rotational, laser), and insurance authorization requirements.
Renal Cryoablation Clinical Compass
Percutaneous Renal Cryoablation Patient Selection & Authorization
A clinical decision support tool for percutaneous renal cryoablation patient selection based on AUA 2021 Renal Mass and Localized Renal Cancer Guidelines (Campbell S, et al. J Urol. 2021), NCCN Kidney Cancer v2.2024, and ACR Appropriateness Criteria 2022. Guides clinicians through R.E.N.A.L. nephrometry scoring, tumor size and complexity assessment, surgical risk stratification, and insurance authorization requirements for T1 renal masses.
Cardiology & Interventional Cardiology
Cardiovascular disease management, interventional cardiology, electrophysiology, and structural heart procedures
Acute Coronary Syndrome Clinical Compass
Acute Coronary Syndrome Decision Support
A unified clinical decision support tool for acute coronary syndrome management based on the 2025 ACC/AHA/SCAI guideline (Rao et al., Circulation 2025). Integrates STEMI and NSTEMI into a single pathway covering risk stratification, early invasive vs. selective strategy, antithrombotic regimen selection with bleeding-risk weighting, and transfusion thresholds.
Dyslipidemia Clinical Compass
Dyslipidemia Decision Support
A comprehensive clinical decision support tool for dyslipidemia management based on the 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline. Guides clinicians through lipid panel assessment, cardiovascular risk stratification, LDL-C treatment goals, statin intensity selection, and non-statin therapies.
Elective PCI Clinical Compass
Elective PCI (Non-ACS) Decision Support
ACC/AHA 2021 PCI Guideline-based decision support for elective percutaneous coronary intervention candidacy. Covers SYNTAX score risk stratification, FFR/iFR-guided revascularization, CABG vs PCI decision support, appropriate use criteria, and insurance authorization requirements.
AF Ablation Clinical Compass
Atrial Fibrillation Ablation Decision Support
ACC/AHA/HRS 2023 AF Guideline-based decision support for catheter ablation candidacy in atrial fibrillation. Covers AF type classification, CHA2DS2-VASc scoring, rhythm vs rate control strategy, ablation timing, anticoagulation management, and insurance authorization requirements.
LAAC / Watchman Clinical Compass
Left Atrial Appendage Closure Decision Support
ACC/AHA/HRS 2023 AF Guideline and WATCHMAN clinical trial-based decision support for left atrial appendage closure (LAAC) device implantation. Covers CHA2DS2-VASc risk stratification, OAC contraindication assessment, PROTECT-AF/PREVAIL trial criteria, and insurance authorization requirements.
Vascular Medicine & Surgery
Peripheral artery disease, venous disorders, and vascular quality improvement
PAD Revascularization Clinical Compass
Lower Extremity PAD Revascularization Decision Support
A comprehensive clinical decision support tool for lower extremity peripheral artery disease (PAD) revascularization based on the 2024 ACC/AHA multisociety guideline (Gornik HL et al., Circulation 2024). Guides clinicians through clinical subset classification (asymptomatic, claudication, CLTI, ALI), GDMT response assessment, anatomic level determination, conduit availability (BEST-CLI/BASIL-2 evidence), WIfI staging, and evidence-based revascularization strategy selection with COR/LOE ratings.
PAD Clinical Performance & Quality Measures Clinical Compass
PAD Clinical Performance & Quality Measures Decision Support
A point-of-care quality assessment tool based on the 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease (Goodney PP et al., JACC 2026). Evaluates all 7 performance measures (PM-1–PM-7: ABI testing, statin therapy, antithrombotic therapy, blood pressure management, ACE inhibitor/ARB therapy, tobacco cessation, supervised exercise therapy) and 8 quality measures (QM-1–QM-8: diabetes management, preventive foot care, novel lipid-lowering therapy, health disparities assessment, saphenous vein mapping, multidisciplinary CLTI care, shared decision-making, post-revascularization surveillance). Identifies care gaps and generates actionable recommendations.
Hematology
Hematologic disorders, anticoagulation, and thrombosis management
Venous Thromboembolism Clinical Compass
Venous Thromboembolism Decision Support
A comprehensive clinical decision support tool for venous thromboembolism (VTE) management based on the American Society of Hematology (ASH) VTE Guideline Suite (2018–2025). Covers five clinical pathways: (1) DVT/PE treatment in non-cancer adults (ASH 2020, PMID 33007077); (2) Cancer-associated thrombosis (ASH 2021, PMID 33570602); (3) Thrombophilia testing (ASH 2023, PMID 37195076); (4) Pediatric VTE including 2025 DOAC update (ASH/ISTH 2025, PMID 40423983); (5) Pregnancy-associated VTE (ASH 2018, PMID 30482763). Generates strength-of-recommendation and certainty-of-evidence rated recommendations.
Acute Myeloid Leukemia Clinical Compass
Acute Myeloid Leukemia Decision Support
Clinical decision support for acute myeloid leukemia (AML) therapy selection based on ELN 2024 risk classification (Döhner H et al., Blood 2022, PMID 36130828) and ASH 2025 AML Guidelines (PMID 39932000). Stratifies patients by fitness (intensive vs non-intensive), ELN 2024 risk (favorable/intermediate/adverse), and key mutations (FLT3-ITD, IDH1/2, NPM1, TP53, CBF). Generates recommendations for induction chemotherapy, venetoclax + HMA, targeted agents (midostaurin, enasidenib, ivosidenib, gilteritinib), and allo-HCT timing.
Acute Lymphoblastic Leukemia & CAR-T Clinical Compass
Acute Lymphoblastic Leukemia & CAR-T Therapy Decision Support
Clinical decision support for acute lymphoblastic leukemia (ALL) treatment pathway decisions including CAR-T cell therapy escalation, based on NCCN ALL Guidelines v3.2025 and ESMO ALL Clinical Practice Guidelines 2024. Covers Ph+ ALL (TKI selection, ponatinib), Ph- B-ALL (blinatumomab, inotuzumab, tisagenlecleucel), T-ALL (nelarabine), and CAR-T eligibility (ZUMA-3, ELIANA, TOWER trial data). Generates recommendations for induction, consolidation, allo-HCT timing, and CAR-T escalation criteria.
Aplastic Anemia Clinical Compass
Aplastic Anemia Decision Support
Clinical decision support for aplastic anemia (AA) management based on ASH 2022 Guidelines (Bhatt VR et al., Blood Advances 2022, PMID 35255491), EBMT/EHA 2024 Guidelines, and NCCN AA v1.2025. Classifies severity using Camitta criteria (vSAA/SAA/NSAA), assesses clonal evolution risk (monosomy 7, PNH clone, MDS features), and generates recommendations for allo-HCT (MSD/MUD/haplo) vs immunosuppression (hATG + CsA + eltrombopag, Townsley NEJM 2017, PMID 28564562). Covers inherited syndromes (Fanconi anemia, dyskeratosis congenita) and second-line options.
Amyloidosis Diagnostic Clinical Compass
Amyloidosis Diagnostic Decision Support
Clinical decision support for amyloidosis diagnosis and treatment selection. Based on the 2023 ACC Expert Consensus Decision Pathway for ATTR-CM (Kittleson MM et al., JACC 2023, PMID 37236727), non-biopsy ATTR-CM criteria (Gillmore JD et al., Lancet 2022, PMID 35240070), ANDROMEDA trial (Kastritis E et al., NEJM 2021, PMID 33951374), ATTR-ACT (Maurer MS et al., NEJM 2018, PMID 30145929), and ATTRibute-CM (Gillmore JD et al., NEJM 2024, PMID 38739481). Detects red flags, classifies AL/ATTR/AA, applies Mayo 2012 staging, and generates diagnostic and treatment pathways.
Neurosurgery & Neuro-Oncology
Brain tumor management, cerebrovascular malformations, and perioperative neurosurgical care
Pituitary Adenoma Clinical Compass
Pituitary Adenoma: Surgery vs Medical Therapy vs Radiosurgery Decision Support
A clinical decision support tool for functioning and non-functioning pituitary adenomas based on CNS 2025 Systematic Review and Evidence-Based Guidelines (Neurosurgery 97(3S), 2025), Endocrine Society guidelines for acromegaly (2014), Cushing's disease (2015), and prolactinoma (2011). Guides clinicians through tumor-type-specific treatment sequencing, cavernous sinus invasion (Knosp grading), surgical approach selection, radiosurgery candidacy, perioperative endocrine management, and postoperative remission criteria.
Vestibular Schwannoma Clinical Compass
Vestibular Schwannoma: Observation vs SRS vs Microsurgery Decision Support
A clinical decision support tool for vestibular schwannoma (acoustic neuroma) management based on CNS 2025 Evidence-Based Clinical Practice Guidelines. Applies AAO-HNS hearing classification, Gardner-Robertson grading, tumor size stratification, and NF2 pathway. Guides observation vs SRS (Gamma Knife) vs microsurgery with hearing preservation thresholds and intraoperative cranial nerve monitoring recommendations.
Brain Metastases Clinical Compass
Brain Metastases: Surgery vs SRS vs Systemic Therapy Decision Support
A clinical decision support tool for brain metastases management based on CNS 2025 Evidence-Based Guidelines (~23 new recommendations), NCCN CNS Tumors 2025, and ESMO 2023. Integrates KPS score, primary histology, driver mutation status (EGFR, ALK, HER2, BRAF), immunotherapy eligibility, lesion count/size, and leptomeningeal disease. Generates SRS vs surgical resection vs WBRT vs systemic therapy recommendations with GPA prognostic scoring.
Low-Grade Glioma Clinical Compass
Diffuse Low-Grade Glioma: Surgery vs Observation vs RT/Chemo Decision Support
A clinical decision support tool for diffuse low-grade glioma (WHO Grade 2) based on CNS 2025 Updated Guidelines, EORTC trials, and RTOG 9802. Applies WHO 2021 molecular classification (IDH1/2, 1p/19q codeletion, MGMT, TERT), eloquent cortex mapping, and INDIGO trial data for vorasidenib. Guides early maximal safe resection vs observation, adjuvant RT timing, and PCV vs temozolomide selection.
Cerebral Cavernous Malformation Compass
Cerebral Cavernous Malformation: Surgery vs Observation vs Radiosurgery Decision Support
A clinical decision support tool for cerebral cavernous malformation (CCM) management based on CNS 2025 Updated Consensus Guidelines and ANGIOMA Alliance 2022 Clinical Care Standards. Applies location-based risk stratification (brainstem, eloquent cortex, deep subcortical, spinal), hemorrhage history, seizure status, genetic testing indications (CCM1/2/3), and surgical candidacy with DVA preservation principles.
Spine Antithrombotic Compass
Spine Surgery: Perioperative Antithrombotic Management Decision Support
A clinical decision support tool for perioperative antithrombotic management in spine surgery based on NASS 2025 Antithrombotic Guideline, ACCP 2022, and AHA/ACC 2022. Covers DOAC hold duration (renal-adjusted), warfarin bridging indications, antiplatelet management for coronary stents, VTE prophylaxis timing, and anticoagulation restart after spine surgery with epidural hematoma risk stratification.
Dermatology
Inflammatory skin disease management, biologic selection, and antibiotic stewardship
Atopic Dermatitis Clinical Compass
Atopic Dermatitis: Topical vs Biologic vs JAK Inhibitor Decision Support
Clinical decision support for atopic dermatitis severity stratification and treatment selection. Based on AAD 2025 Focused Update (tapinarof, roflumilast, lebrikizumab, nemolizumab), AAD 2026 systemic therapy update (JAK inhibitor vs biologic selection), and AAD 2023 guidelines (Sidbury R et al., JAAD 2023, PMID 37225497). Integrates IGA/EASI/SCORAD severity, prior treatment failure, age-specific thresholds, and contraindication screening.
Acne Vulgaris Clinical Compass
Acne Vulgaris: Topical vs Systemic vs Isotretinoin Decision Support
Clinical decision support for acne vulgaris severity stratification and treatment selection. Based on AAD 2024 Acne Guideline (Zaenglein AL et al., JAAD 2024), antibiotic stewardship principles (limit oral antibiotics ≤3 months), hormonal therapy pathways (spironolactone, OCPs), and iPLEDGE isotretinoin criteria. Integrates PGA scoring, morphology, prior treatment failure, hormonal considerations, and safety screening.
Psoriasis Clinical Compass
Psoriasis: Topical vs Biologic vs TYK2 Inhibitor Decision Support
Clinical decision support for psoriasis severity stratification and biologic/systemic therapy selection. Based on AAD-NPF 2019 guidelines (Menter A et al., JAAD 2019, PMID 30772097), AAD-NPF 2020 biologics update (PMID 31703821), and anticipated 2026 update incorporating TYK2 inhibitors (deucravacitinib) and new IL-17/IL-23 agents. Integrates BSA, DLQI, PGA, special sites, psoriatic arthritis, and contraindication screening.
Neurology
Stroke, epilepsy, migraine, MS, and Parkinson's disease decision support
Functional Seizures (PNES)
Diagnosis, Differentiation from Epilepsy, and Treatment — Decision Support
Clinical decision support for functional seizures (PNES) diagnosis and management. Based on AAN 2025 Practice Guideline (LaFrance WC et al.), ILAE 2022 diagnostic criteria, and CBT/psychotherapy evidence. Differentiates PNES from epilepsy, guides video-EEG indication, and generates treatment pathways.
Acute Ischemic Stroke
tPA, Thrombectomy, Anticoagulation, and Secondary Prevention — Decision Support
Clinical decision support for acute ischemic stroke management. Based on AHA/ASA 2026 Stroke Guidelines, DAWN/DEFUSE-3 thrombectomy trials, and ESUS/AF secondary prevention evidence. Guides tPA eligibility, thrombectomy window, anticoagulation timing, and secondary prevention strategy.
Migraine
Acute and Preventive Therapy, CGRP Pathway, Biologic Selection — Decision Support
Clinical decision support for migraine management. Based on AAN/AHS 2025 guidelines, CGRP monoclonal antibody trials (EVOLVE, REGAIN, DELIVER), and gepant/lasmiditan acute therapy evidence. Stratifies episodic vs chronic migraine, guides biologic selection, and flags medication overuse.
Multiple Sclerosis
DMT Selection, Escalation, JC Virus Risk, and BTK Inhibitor Pathway — Decision Support
Clinical decision support for MS disease-modifying therapy selection. Based on AAN/ECTRIMS 2025 guidelines, BTK inhibitor phase 3 data (fenebrutinib, tolebrutinib), and JC virus risk stratification. Guides early high-efficacy therapy, natalizumab JCV risk, and progressive MS management.
Parkinson's Disease
Levodopa Timing, DBS Candidacy, Neuroprotection, and Non-Motor Management — Decision Support
Clinical decision support for Parkinson's disease management. Based on MDS 2025 guidelines, DBS candidacy criteria (EARLYSTIM trial), and GLP-1 neuroprotection evidence. Guides levodopa initiation, motor complication management, DBS eligibility, and non-motor symptom treatment.
Ophthalmology
Retinal disease, glaucoma, and myopia management decision support
Age-Related Macular Degeneration
Anti-VEGF Selection, Dry AMD Monitoring, and Supplement Therapy — Decision Support
Clinical decision support for AMD management. Based on AAO 2024 Preferred Practice Pattern, AREDS2 supplement data, and faricimab/high-dose aflibercept anti-VEGF evidence. Guides AREDS2 supplementation, anti-VEGF agent selection, treat-and-extend protocols, and geographic atrophy management.
High Myopia / Pathologic Myopia
Progression Control, Complication Screening, and Surgical Candidacy — Decision Support
Clinical decision support for high myopia and pathologic myopia management. Based on IMI 2023 guidelines and AAO 2024 PPP. Guides myopia control (atropine, orthokeratology, MiSight), complication screening (myopic maculopathy, retinal detachment), and refractive surgery candidacy.
Glaucoma
Medication vs SLT vs Surgery, Target IOP, and Monitoring — Decision Support
Clinical decision support for glaucoma management. Based on AAO 2026 Preferred Practice Pattern, EGS 2024 guidelines, and OHTS/CIGTS/LiGHT trial evidence. Guides target IOP setting, first-line medication selection, SLT vs drops decision, MIGS vs trabeculectomy, and monitoring frequency.
Gastroenterology & Interventional GI
IBD, MASLD, gastroparesis, CRC screening, EUS, and biliary disease decision support
Crohn's Disease Clinical Compass
Biologic & Small Molecule Sequencing, Top-Down Strategy, Treat-to-Target — Decision Support
Clinical decision support for Crohn's disease management. Based on ACG Clinical Guideline 2025. Guides biologic and small molecule sequencing (anti-TNF, IL-12/23, IL-23, JAK inhibitors, S1P modulators), early advanced therapy (top-down), treat-to-target (endoscopic healing), and perianal disease management.
Ulcerative Colitis Clinical Compass
Mechanism-Based Biologic Selection, IL-23 / JAK / S1P Sequencing, Colectomy Timing — Decision Support
Clinical decision support for ulcerative colitis management. Based on ACG 2025 and AGA Living Guideline 2025. Guides mechanism-based agent selection (IL-23s, JAKs, S1Ps), combination and sequencing strategies, acute severe UC management, and colectomy decision-making.
MASLD / MASH Clinical Compass
Fibrosis Risk Stratification, Resmetirom / GLP-1 Selection, Cardiometabolic Integration — Decision Support
Clinical decision support for MASLD and MASH management. Based on AGA Clinical Practice Update 2025 and ACG guideline. Guides noninvasive fibrosis scoring (FIB-4, ELF, LSM), resmetirom candidacy (FDA-approved MASH therapy), GLP-1 receptor agonist integration, and cardiometabolic risk reduction.
Gastroparesis Clinical Compass
Diagnostic Testing, Medication Hierarchy, Dietary Management, Shared Decision-Making — Decision Support
Clinical decision support for gastroparesis management. Based on the first-ever AGA Clinical Guideline on Gastroparesis (2025). Guides 4-hour gastric emptying scintigraphy, medication hierarchy (metoclopramide, domperidone, erythromycin), dietary modification, and device-based therapies with explicit acknowledgment of limited evidence quality.
CRC Screening Clinical Compass
Age 45 Initiation, Stool-Based vs Colonoscopy Hybrid Strategies, High-Risk Surveillance — Decision Support
Clinical decision support for colorectal cancer screening. Based on multi-society framework (ACG/ACS/USPSTF/USMSTF 2025). Guides screening initiation at age 45, stool-based vs colonoscopy hybrid strategies, high-risk surveillance (family history, IBD, polyp history), and post-polypectomy intervals.
IBD Preventive Care Clinical Compass
Vaccination, Infection Risk Stratification, Cancer Prevention, Portal Vein Thrombosis — Decision Support
Clinical decision support for IBD preventive care and complications. Based on AGA Clinical Practice Update 2025. Guides vaccination protocols under immunosuppression, infection risk stratification, CRC surveillance in IBD, gastric cancer screening, and portal vein thrombosis management.
Pancreatic Mass Evaluation Clinical Compass
EUS-FNB vs FNA, IPMN Surveillance, Molecular Diagnostics, Resectability — Decision Support
Clinical decision support for pancreatic mass evaluation. Based on ASGE Guideline on EUS-Guided Tissue Acquisition (2024 Update), NCCN Pancreatic Adenocarcinoma Guidelines (2025), and IAP/APA IPMN Guidelines (2023). Guides solid vs cystic mass workup, EUS-FNB vs FNA selection, molecular diagnostics, IPMN surveillance intervals, and resectability assessment.
Therapeutic EUS Clinical Compass
EUS-Guided Biliary Drainage, LAMS, EUS-BD vs ERCP vs IR — Decision Support
Clinical decision support for therapeutic EUS. Based on ASGE Guideline on EUS-Guided Biliary and Pancreatic Duct Interventions (2025 Update) and ESGE EUS-BD Guideline (2022). Guides EUS-CDS vs EUS-HGS selection, LAMS vs plastic stent, EUS-GBD for acute cholecystitis, and EUS-guided pancreatic duct drainage.
Chronic Pancreatitis Clinical Compass
Endoscopic vs Surgical Drainage, ESWL, PERT, Pain Management — Decision Support
Clinical decision support for chronic pancreatitis management. Based on ASGE Guideline on Endoscopic Therapy for Chronic Pancreatitis (2024 Update), ACG Clinical Guideline on Chronic Pancreatitis (2020), and ESGE Guideline (2023). Guides endoscopic vs surgical drainage decision, ESWL candidacy, PERT dosing, type 3c diabetes management, and pseudocyst drainage.
Biliary Strictures Clinical Compass
Malignancy Workup, Tissue Acquisition, ERCP vs EUS Sequencing, PSC — Decision Support
Clinical decision support for biliary strictures and malignancy workup. Based on ASGE Guideline on Biliary Strictures (2024 Update), ESGE Guideline (2022), ACG PSC Guideline (2023), and NCCN Biliary Tract Cancers (2025). Guides benign vs malignant differentiation, tissue acquisition strategy, ERCP vs EUS sequencing, PSC dominant stricture management, and hilar vs distal classification.
Pediatrics
Immunization schedules, well-child care, neonatal, febrile infant, obesity, and mental health decision support
Pediatric Immunization Clinical Compass
AAP 2026 Catch-Up Schedule, Special Populations, Contraindications — Decision Support
Clinical decision support for pediatric immunization scheduling. Based on AAP/ACIP 2026 Recommended Childhood Immunization Schedule. Guides age-appropriate vaccine selection, catch-up scheduling, special population considerations (prematurity, immunocompromise, asplenia), contraindication screening, and combination vaccine strategy.
Bright Futures Well-Child Clinical Compass
AAP Bright Futures 2025, Developmental Surveillance, Anticipatory Guidance — Decision Support
Clinical decision support for well-child preventive care. Based on AAP Bright Futures 4th Edition (2025 Update). Guides visit-specific developmental surveillance, standardized screening (M-CHAT, ASQ, PHQ-A, CRAFFT), anticipatory guidance topics, and referral thresholds by age.
Pediatric Obesity Clinical Compass
AAP CPG 2023/2026 Intensive Behavioral Therapy, GLP-1 RA, Bariatric Surgery — Decision Support
Clinical decision support for pediatric obesity management. Based on AAP Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity (2023/2026 Update). Guides BMI percentile classification, intensive health behavior and lifestyle treatment (IHBLT), pharmacotherapy (orlistat, metformin, semaglutide ≥12y), and bariatric surgery candidacy.
Febrile Infant Clinical Compass
AAP 2021/2025 PECARN Criteria, SBI Risk Stratification, HSV — Decision Support
Clinical decision support for febrile infant evaluation. Based on AAP Clinical Practice Guideline on Febrile Infants 8–60 Days (2021) and PECARN Low-Risk Criteria (2025 Update). Guides age-stratified workup (0–28, 29–60, 61–90 days), SBI risk stratification, LP decision, empiric antibiotic selection, HSV risk assessment, and admission vs discharge criteria.
Neonatal Hyperbilirubinemia Clinical Compass
AAP 2022 Phototherapy Thresholds, Exchange Transfusion, Neurotoxicity Risk — Decision Support
Clinical decision support for neonatal hyperbilirubinemia management. Based on AAP Clinical Practice Guideline on Jaundice in Newborns ≥35 Weeks (2022). Guides gestational-age-adjusted phototherapy thresholds, exchange transfusion thresholds, neurotoxicity risk stratification, intensive phototherapy criteria, and discharge readiness assessment.
Influenza Prevention Clinical Compass
AAP 2025–2026 Season, Vaccine Selection, Oseltamivir, Baloxavir — Decision Support
Clinical decision support for pediatric influenza prevention and treatment. Based on AAP Policy Statement on Influenza Prevention and Control (2025–2026 Season). Guides vaccine type selection (IIV4 vs LAIV4), dose scheduling for first-season recipients, high-risk group identification, antiviral treatment (oseltamivir, baloxavir, peramivir), chemoprophylaxis, and egg allergy management.
RSV Prevention Clinical Compass
AAP 2024 Nirsevimab, Palivizumab, Maternal Abrysvo — Decision Support
Clinical decision support for RSV prevention in infants and young children. Based on AAP Policy Statement on Immunoprophylaxis for RSV Disease (2024) and updated nirsevimab (Beyfortus) guidance. Guides nirsevimab vs palivizumab selection, dosing by weight, high-risk group identification (CHD, BPD, prematurity), maternal Abrysvo vaccination interaction, and seasonal timing.
Pediatric Mental Health Clinical Compass
AAP 2023/2025 PHQ-9, SCARED, CRAFFT, Suicide Safety Planning — Decision Support
Clinical decision support for pediatric mental health screening and management. Based on AAP Policy Statement on Mental Health Competencies for Pediatric Practice (2023/2025 Update), AAP Suicide Prevention Guideline (2024), and USPSTF Recommendations. Guides PHQ-9/GAD-7/SCARED/CRAFFT score interpretation, suicide risk stratification, means restriction counseling, referral thresholds, and first-line treatment selection (CBT, SSRI, ADHD medication).
Radiation Oncology
NCCN 2025-2026 and ASTRO guideline-based RT decision support across CNS, H&N, lung, prostate, GI, lymphoma, breast, skin, and palliative disease sites
Radiation Oncology Clinical Compass
NCCN 2025–2026 & ASTRO guideline-based RT recommendations across 13 disease sites — Decision Support
Comprehensive radiation oncology clinical decision support based on NCCN 2025–2026 and ASTRO guidelines. Covers CNS tumors (GBM, LGG, brain mets, meningioma), head & neck cancers (oropharynx, larynx, NPC, oral cavity), NSCLC (stages I–IV, SBRT, concurrent CRT, immunotherapy consolidation), SCLC (limited vs extensive stage, PCI), prostate cancer (all risk groups, SBRT, ADT sequencing, post-prostatectomy RT), esophageal/GEJ, gastric (ASTRO 2025 first dedicated guideline), rectal cancer (TNT, watch-and-wait), lymphoma (Hodgkin, DLBCL, follicular), HCC (SBRT, TACE+RT, transplant bridge), breast (APBI, hypofractionation, preoperative RT), skin (BCC, cSCC), and palliative/oligometastatic disease (SBRT/SABR). Includes dose/fractionation, target volumes, technique selection (IMRT, SBRT, SRS, VMAT), concurrent systemic therapy, and MDT consultation recommendations.
Psychiatry
APA 2025-2026 and VA/DoD guideline-based decision support for delirium, depression, BPD, schizophrenia, PTSD, eating disorders, benzodiazepine tapering, and suicide risk assessment
Psychiatry Clinical Compass
APA 2025-2026 & VA/DoD guideline-based psychiatric decision support - Decision Support
Evidence-based psychiatric decision support integrating APA 2025-2026 and VA/DoD guidelines. Covers delirium (2025 paradigm shift: avoid antipsychotics for prevention), borderline personality disorder (psychotherapy-first), major depressive disorder (including TRD and esketamine), schizophrenia (antipsychotics, clozapine, LAI), PTSD (trauma-focused psychotherapy), eating disorders (family-based therapy, multidisciplinary care), benzodiazepine tapering (individualized protocols), bipolar disorder (mood stabilizers), and suicide risk assessment (VA/DoD framework). Includes safety considerations, monitoring parameters, and MDT consultation.
Orthopedics & Spine Surgery
AAOS and NASS guideline-based decision support for joint replacement, spinal fusion, disc replacement, and arthroscopic procedures
Spinal Fusion Clinical Compass
Spinal Fusion Decision Support
NASS Evidence-Based Clinical Guideline-based decision support for lumbar and cervical spinal fusion candidacy, ODI/NDI functional assessment, conservative therapy requirements, and neurologic deficit evaluation.
Artificial Disc Replacement Clinical Compass
Artificial Disc Replacement Decision Support
FDA indication and NASS guideline-based decision support for cervical and lumbar artificial disc replacement candidacy, contraindication screening, and comparison with spinal fusion.
Pain Medicine & Interventional Procedures
ASIPP, ISIS, and NASS guideline-based decision support for epidural steroid injections, facet interventions, RFA, and spinal cord stimulation
Epidural Steroid Injection Clinical Compass
Epidural Steroid Injection Decision Support
ASIPP and ISIS guideline-based decision support for epidural steroid injection candidacy, approach selection (interlaminar vs. transforaminal vs. caudal), frequency limits, and prior authorization requirements.
Facet Joint Injection Clinical Compass
Facet Joint Injection / Medial Branch Block Decision Support
ASIPP and ISIS guideline-based decision support for facet joint injection and medial branch block candidacy, diagnostic vs. therapeutic injection selection, and RFA eligibility criteria.
Radiofrequency Ablation Clinical Compass
Radiofrequency Ablation Decision Support
ASIPP and ISIS guideline-based decision support for lumbar and cervical radiofrequency ablation candidacy, diagnostic MBB response requirements, repeat RFA criteria, and insurance authorization requirements.
Spinal Cord Stimulator Clinical Compass
Spinal Cord Stimulator Trial/Implant Decision Support
ASIPP, NANS, and ISIS guideline-based decision support for spinal cord stimulator trial and permanent implant candidacy, psychological screening requirements, trial response criteria, and insurance authorization requirements.
General Surgery & GI Surgery
ASMBS, SAGES, and ACS guideline-based decision support for bariatric surgery, cholecystectomy, and hernia repair
Bariatric Surgery Clinical Compass
Bariatric Surgery (Sleeve / Bypass) Decision Support
ASMBS/IFSO 2022 Indications for Metabolic and Bariatric Surgery-based decision support for sleeve gastrectomy and Roux-en-Y gastric bypass candidacy. Covers BMI-based eligibility, comorbidity weighting, psychological evaluation requirements, nutritional assessment, and insurance authorization requirements.
Cholecystectomy Clinical Compass
Elective Cholecystectomy Decision Support
SAGES and ACS guideline-based decision support for elective laparoscopic cholecystectomy candidacy. Covers symptomatic cholelithiasis criteria, biliary colic vs acute cholecystitis differentiation, ERCP/MRCP indications for choledocholithiasis, and insurance authorization requirements.
Hernia Repair Clinical Compass
Non-Emergent Hernia Repair Decision Support
HerniaSurge Group International Guidelines (2018) and ACS guideline-based decision support for elective hernia repair candidacy. Covers hernia type classification (inguinal, umbilical, ventral/incisional, hiatal), watchful waiting vs repair decision, mesh vs tissue repair selection, and insurance authorization requirements.
Plastic & Reconstructive Surgery
ASPS and CMS guideline-based decision support for breast reduction and functional blepharoplasty/ptosis repair
Breast Reduction Clinical Compass
Reduction Mammoplasty Decision Support
ASPS Evidence-Based Clinical Practice Guideline for Reduction Mammaplasty (2011) and CMS LCD L35041-based decision support for reduction mammoplasty candidacy. Covers Schnur Scale calculation, functional symptom documentation, conservative treatment requirements, and insurance authorization requirements.
Blepharoplasty / Ptosis Repair Clinical Compass
Functional Blepharoplasty & Ptosis Repair Decision Support
CMS LCD L34462 and AAO Preferred Practice Pattern for Ptosis (2018)-based decision support for functional upper blepharoplasty and ptosis repair candidacy. Covers visual field testing criteria (>=12 degrees superior field loss), MRD1 measurement for ptosis (<=2mm), levator function assessment, ectropion/entropion/lagophthalmos repair indications, and insurance authorization requirements.
Urology & Male Reproductive Medicine
AUA and WPATH guideline-based decision support for vasectomy reversal, varicocelectomy, TESE/micro-TESE, Peyronie's disease surgery, and gender-affirming urologic procedures
Vasectomy Reversal Clinical Compass
Vasectomy Reversal Decision Support
A clinical decision support tool for vasectomy reversal (vasovasostomy / vasoepididymostomy) patient selection based on AUA 2021 Male Infertility guidelines. Guides clinicians through obstructive interval analysis, sperm granuloma assessment, vasovasostomy vs. vasoepididymostomy decision, and insurance authorization requirements with appeal letter generation.
Varicocelectomy Clinical Compass
Varicocelectomy for Infertility Decision Support
A clinical decision support tool for varicocelectomy in male infertility based on AUA 2021 Male Infertility guidelines and EAU 2024 Male Infertility guidelines. Covers WHO semen analysis criteria, varicocele grading (Dubin-Amelar), surgical approach selection (microsurgical subinguinal, laparoscopic, open inguinal), and insurance authorization with appeal letter generation.
TESE / Micro-TESE Clinical Compass
TESE / Micro-TESE for Male Infertility Decision Support
A clinical decision support tool for testicular sperm extraction (TESE / micro-TESE) in non-obstructive azoospermia based on AUA 2021 Male Infertility guidelines. Covers FSH/inhibin B thresholds, testicular volume assessment, genetic workup (karyotype, Y-chromosome microdeletion), micro-TESE vs. conventional TESE selection, and insurance authorization with appeal letter generation.
Peyronie's Disease Surgery Clinical Compass
Peyronie's Disease Surgical Management Decision Support
A clinical decision support tool for Peyronie's disease surgical management based on AUA 2015 (amended 2022) Peyronie's Disease guidelines. Covers disease phase assessment (active vs. stable), penile curvature quantification, erectile function assessment (IIEF-EF), surgical approach selection (plication vs. grafting vs. penile prosthesis), and insurance authorization with appeal letter generation.
Gender-Affirming Urologic Procedures Clinical Compass
Gender-Affirming Urologic Procedures Decision Support
A clinical decision support tool for gender-affirming urologic procedures based on WPATH Standards of Care Version 8 (2022) and AUA guidelines. Covers criteria assessment for vaginoplasty, phalloplasty, metoidioplasty, and orchiectomy; persistent gender dysphoria documentation; mental health evaluation requirements; hormone therapy duration; and insurance authorization with appeal letter generation.
Reproductive Endocrinology & Infertility
ASRM and ASCO guideline-based decision support for IVF, ICSI, PGT, oocyte cryopreservation, embryo cryopreservation, ovulation induction, and gestational carrier procedures
In Vitro Fertilization Clinical Compass
IVF Decision Support
A clinical decision support tool for in vitro fertilization (IVF) based on ASRM 2023 guidelines and state fertility mandate requirements. Covers infertility definition (12-month criterion), prior treatment failure documentation (IUI, ovulation induction), ovarian reserve assessment (AMH, AFC), controlled ovarian stimulation protocol selection, and insurance authorization with evidence-based appeal letter generation addressing plan exclusion and cycle limit denials.
Intracytoplasmic Sperm Injection Clinical Compass
ICSI Decision Support
A clinical decision support tool for intracytoplasmic sperm injection (ICSI) based on ASRM 2023 guidelines. Covers male factor infertility indications (severe oligospermia, azoospermia, TESE sperm, anti-sperm antibodies), prior fertilization failure, and insurance authorization with appeal letter generation addressing 'add-on' denials.
Preimplantation Genetic Testing Clinical Compass
PGT-A / PGT-M Decision Support
A clinical decision support tool for preimplantation genetic testing (PGT-A and PGT-M) based on ASRM 2023 guidelines and ACMG recommendations. Covers PGT-A indications (advanced maternal age, recurrent pregnancy loss, recurrent implantation failure), PGT-M indications (known genetic disorder, carrier status), and insurance authorization with appeal letter generation addressing 'screening' denials.
Oocyte Cryopreservation Clinical Compass
Oocyte Cryopreservation Decision Support
A clinical decision support tool for oocyte cryopreservation (egg freezing) based on ASRM 2023 guidelines. Covers medical indications (oncofertility, gonadotoxic therapy, premature ovarian insufficiency risk), elective fertility preservation, ovarian reserve assessment, and insurance authorization with appeal letter generation addressing medical necessity for oncofertility cases.
Embryo Cryopreservation Clinical Compass
Embryo Cryopreservation & FET Decision Support
A clinical decision support tool for embryo cryopreservation and frozen embryo transfer (FET) based on ASRM 2023 guidelines and ASCO 2018 oncofertility guidelines. Covers freeze-all strategy (OHSS prevention, endometrial optimization), oncofertility embryo banking, PGT-required cryopreservation, and insurance authorization with appeal letter generation.
Ovulation Induction Clinical Compass
Ovulation Induction & Monitoring Decision Support
A clinical decision support tool for ovulation induction based on ASRM 2023 guidelines and Endocrine Society guidelines. Covers PCOS/anovulation diagnosis, letrozole vs. clomiphene first-line therapy, gonadotropin protocol selection (follitropin alfa, menotropins), monitoring requirements (ultrasound, estradiol), and insurance authorization with appeal letter generation addressing 'not medically necessary' and benefit exclusion denials.
Gestational Carrier Clinical Compass
Gestational Carrier (Surrogacy) Decision Support
A clinical decision support tool for gestational carrier (surrogacy) procedures based on ASRM 2022 Practice Committee guidelines and ACOG Committee Opinion No. 660. Covers absolute uterine factor indications (MRKH, surgical absence, Asherman syndrome), medical contraindications to pregnancy, ASRM carrier screening requirements, and insurance authorization with appeal letter generation addressing surrogacy exclusion denials.